Weeks after the global public health community sounded the alarm on the shortage of cholera vaccine, the World Health Organization moved to prequalify a new cholera vaccine last month. The vaccine is a simplified version of the two existing oral vaccines, both produced by Korean vaccine manufacturer EuBiologics Co.
The company will begin making the new vaccine, called Euvichol-S, this year. “We simplified the formulation, which reduces the complexity, the cost, and the time for producing the vaccine,” said Julia Lynch, the director of the cholera program at the International Vaccine Institute, a nonprofit that codeveloped the cholera vaccines with EuBiologics Co. “With this simplified formulation, it’s expected that we’ll increase the production capacity by about 40% — using the same personnel, the same facilities.”
Click this link for the original source of this article.
Author: Annalisa Merelli
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.